GlassScriptPhysician profile
Hannah Lynch
NPI 1952962896
$3,667.35
in general payments reported to CMS, 2019-2025
18 companies · $665 in 2025
The $665 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $409 · 2020: $649 · 2021: $806 · 2022: $157 · 2023: $501 · 2024: $481 · 2025: $665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,647.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,646.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $650.52 | 2019-2025 | Rocklatan, Tryptyr, Eysuvis |
| Johnson & Johnson Vision Care, INC. | $625.45 | 2020-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $399.63 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $390.42 | 2022-2025 | Miebo, Xiidra |
| Oyster Point Pharma, INC. | $373.14 | 2023-2025 | Tyrvaya, Ryzumvi |
| Tarsus Pharmaceuticals, INC. | $307.88 | 2024-2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $258.84 | 2021-2023 | |
| Sun Pharmaceutical Industries INC. | $155.90 | 2022-2025 | Cequa |
| Sight Sciences, INC. | $123.49 | 2019 | |
| Dompe US, INC. | $72.20 | 2022-2023 | Oxervate |
| Abbvie INC. | $67.46 | 2023 | |
| Coopervision INC. | $56.71 | 2020-2022 | |
| Rxsight INC | $51.35 | 2023-2025 | Rxsight Injector Cartridge, Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd) |
| Mallinckrodt Hospital Products INC. | $42.88 | 2024 | Acthar |
| Glaukos Corporation | $29.81 | 2025 | Photrexa Viscous and Photrexa, Kxl System (Not Refurbished) |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $26.64 | 2025 | Vevye |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Allergan, INC. | $15.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Lynch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.